Tech Company Financing Transactions
Oricula Therapeutics Funding Round
Oricula Therapeutics secured a funding round on 4/11/2014. Backers included University of Washington.
Transaction Overview
Company Name
Announced On
4/11/2014
Transaction Type
Venture Equity
Amount
Unknown
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
474 39th Ave. East
Seattle, WA 98112
USA
Seattle, WA 98112
USA
Phone
Website
Email Address
Not Recorded
Overview
Oricula Therapeutics LLC develops and commercializes drugs to prevent hearing loss. The company was incorporated in 2013 and is based in Seattle, Washington.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Malcolm Gleser
VP - Bus. Development
Marc Bailie
Browse more venture capital transactions:
Prev: 4/11/2014: eTect venture capital transaction
Next: 4/11/2014: Shadow Networks venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on every notable VC transaction. All VC database entries reported here are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs